Direct luteotrophic effect of oestradiol-17 beta on pig corpora lutea.
Five gilts each received intraluteal implants releasing about 4.4 +/- 1.1 (Group 1), 15.0 +/- 1.1 (Group 2) or 22.4 +/- 1.0 (Group 3) micrograms oestradiol/day as determined by in-vitro incubation of implants of similar weight and oestradiol content. On Day 11 of the oestrous cycle (Day 0 = first day of oestrus), 3 CL in one ovary received oestradiol implants, 3 CL in the other ovary received vehicle implants, and all other CL in both ovaries served as uninjected control CL. An additional group of 6 animals served as controls and included 4 animals receiving bilateral vehicle implants (3 CL per ovary) on Day 11 and 2 unoperated gilts. All animals were slaughtered on Day 19 of their oestrous cycle, and the weight, progesterone content and concentration of each CL were determined. In Group 3 gilts, luteal weight, progesterone content and concentration were greater by 68.7 +/- 24.0 mg, 6.54 +/- 1.33 micrograms and 7.54 +/- 2.00 ng/ml respectively (P less than 0.01) in oestradiol-implanted CL than in vehicle-implanted CL, which appeared to be similar to uninjected control CL. No differences were seen between oestradiol-17 beta and vehicle-treated CL in CL from gilts in Groups 1 or 2. All CL of Group 3 gilts were heavier and contained a greater content and concentration of progesterone (P less than 0.01) than gilts in Groups 1 and 2, and in controls for which the values were similar.(ABSTRACT TRUNCATED AT 250 WORDS)
Conley
A J
AJ
Department of Animal Science, Iowa State University, Ames 50011.
Ford
S P
SP
D000818:Animals; D003338:Corpus Luteum / Q000032:analysis / Q000033:anatomy & histology / Q000187:drug effects*; D003340:Corpus Luteum Maintenance / Q000187:drug effects*; D004343:Drug Implants; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D009929:Organ Size; D011247:Pregnancy; D011374:Progesterone / Q000032:analysis; D013552:Swine
D004343:Drug Implants; D011374:Progesterone; D004958:Estradiol